{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:21:56Z","timestamp":1785306116818,"version":"3.55.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T00:00:00Z","timestamp":1655510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA009001"],"award-info":[{"award-number":["T32 CA009001"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA87969"],"award-info":[{"award-number":["P01 CA87969"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA49449"],"award-info":[{"award-number":["R01 CA49449"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["U01 CA176726"],"award-info":[{"award-number":["U01 CA176726"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007316","name":"Division of Cancer Prevention, National Cancer Institute","doi-asserted-by":"publisher","award":["R01 CA67262"],"award-info":[{"award-number":["R01 CA67262"]}],"id":[{"id":"10.13039\/100007316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2022,10,5]]},"DOI":"10.1038\/s41416-022-01873-9","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T14:02:53Z","timestamp":1655560973000},"page":"1076-1085","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A metabolomic analysis of adiposity measures and pre- and postmenopausal breast cancer risk in the Nurses\u2019 Health Studies"],"prefix":"10.1038","volume":"127","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0084-4775","authenticated-orcid":false,"given":"Kristen D.","family":"Brantley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oana A.","family":"Zeleznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A.","family":"Dickerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raji","family":"Balasubramanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Avila-Pacheco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6907-0056","authenticated-orcid":false,"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rulla M.","family":"Tamimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Heather","family":"Eliassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,18]]},"reference":[{"key":"1873_CR1","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ijc.20315","volume":"111","author":"PH Lahmann","year":"2004","unstructured":"Lahmann PH, Hoffmann K, Allen N, van Gils C, Khaw KT, Tehard B, et al. Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer. 2004;111:762\u201371.","journal-title":"Int J Cancer"},{"key":"1873_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1023\/A:1020239211145","volume":"13","author":"LM Morimoto","year":"2002","unstructured":"Morimoto LM, White E, Chen Z, Chlebowski RT, Hays J, Kuller L, et al. Obesity, body size, and risk of postmenopausal breast cancer: the Women\u2019s Health Initiative (United States). Cancer Causes Control. 2002;13:741\u201351.","journal-title":"Cancer Causes Control"},{"key":"1873_CR3","doi-asserted-by":"publisher","first-page":"e51446","DOI":"10.1371\/journal.pone.0051446","volume":"7","author":"Z Cheraghi","year":"2012","unstructured":"Cheraghi Z, Poorolajal J, Hashem T, Esmailnasab N, Doosti, Irani A. Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis. PLoS ONE. 2012;7:e51446.","journal-title":"PLoS ONE"},{"key":"1873_CR4","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","volume":"371","author":"AG Renehan","year":"2008","unstructured":"Renehan AG, Tyson M, Egger M, Heller RF, Zwahlen M. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies. Lancet. 2008;371:569\u201378.","journal-title":"Lancet."},{"key":"1873_CR5","doi-asserted-by":"publisher","first-page":"e181771","DOI":"10.1001\/jamaoncol.2018.1771","volume":"4","author":"MJ Schoemaker","year":"2018","unstructured":"Premenopausal Breast Cancer Collaborative Group, Schoemaker MJ, Nichols HB, Wright LB, Jones ME, O\u2019Brien KM, Adami HO, et al. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncol. 2018;4:e181771.","journal-title":"JAMA Oncol."},{"key":"1873_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/ijc.32710","volume":"147","author":"J Luo","year":"2020","unstructured":"Luo J, Chen X, Manson JE, Shadyab AH, Wactawski-Wende J, Vitolins M, et al. Birth weight, weight over the adult life course and risk of breast cancer. Int J Cancer. 2020;147:65\u201375.","journal-title":"Int J Cancer"},{"key":"1873_CR7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1210\/jc.2011-1151","volume":"97","author":"A Hartz","year":"2012","unstructured":"Hartz A, He T, Rimm A. Comparison of adiposity measures as risk factors in postmenopausal women. J Clin Endocrinol Metab. 2012;97:227\u201333.","journal-title":"J Clin Endocrinol Metab"},{"key":"1873_CR8","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1017\/S0007114517002665","volume":"118","author":"DH Lee","year":"2017","unstructured":"Lee DH, Keum N, Hu FB, Orav EJ, Rimm EB, Sun Q, et al. Development and validation of anthropometric prediction equations for lean body mass, fat mass and percent fat in adults using the National Health and Nutrition Examination Survey (NHANES) 1999-2006. Br J Nutr. 2017;118:858\u201366.","journal-title":"Br J Nutr"},{"key":"1873_CR9","doi-asserted-by":"crossref","unstructured":"Moore SC, Mazzilli KM, Sampson JN, Matthews CE, Carter BD, Playdon MC, et al. A metabolomics analysis of postmenopausal breast cancer risk in the cancer prevention study II. Metabolites. 2021;11:95.","DOI":"10.3390\/metabo11020095"},{"key":"1873_CR10","first-page":"588","volume":"110","author":"SC Moore","year":"2018","unstructured":"Moore SC, Playdon MC, Sampson JN, Hoover RN, Trabert B, Matthews C, et al. A metabolomics analysis of body mass index and postmenopausal breast cancer risk. J Natl Cancer Inst. 2018;110:588\u201397.","journal-title":"J Natl Cancer Inst"},{"key":"1873_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s11306-013-0574-1","volume":"10","author":"SC Moore","year":"2014","unstructured":"Moore SC, Matthews CE, Sampson JN, Stolzenberg-Solomon RZ, Zheng W, Cai Q, et al. Human metabolic correlates of body mass index. Metabolomics. 2014;10:259\u201369.","journal-title":"Metabolomics."},{"key":"1873_CR12","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","volume":"125","author":"S Cheng","year":"2012","unstructured":"Cheng S, Rhee EP, Larson MG, Lewis GD, McCabe EL, Shen D, et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation. 2012;125:2222\u201331.","journal-title":"Circulation."},{"key":"1873_CR13","doi-asserted-by":"publisher","first-page":"3216","DOI":"10.1210\/jc.2012-1490","volume":"97","author":"MM Gaudet","year":"2012","unstructured":"Gaudet MM, Falk RT, Stevens RD, Gunter MJ, Bain JR, Pfeiffer RM, et al. Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. J Clin Endocrinol Metab. 2012;97:3216\u201323.","journal-title":"J Clin Endocrinol Metab"},{"key":"1873_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/nm.3868","volume":"21","author":"ID Mascanfroni","year":"2015","unstructured":"Mascanfroni ID, Takenaka MC, Yeste A, Patel B, Wu Y, Kenison JE, et al. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-\u03b1. Nat Med. 2015;21:638\u201346. https:\/\/doi.org\/10.1038\/nm.3868","journal-title":"Nat Med"},{"key":"1873_CR15","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1172\/JCI95995","volume":"127","author":"JF O\u2019Sullivan","year":"2017","unstructured":"O\u2019Sullivan JF, Morningstar JE, Yang Q, Zheng B, Gao Y, Jeanfavre S, et al. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J Clin Invest. 2017;127:4394\u2013402.","journal-title":"J Clin Invest"},{"key":"1873_CR16","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","volume":"137","author":"NP Paynter","year":"2018","unstructured":"Paynter NP, Balasubramanian R, Giulianini F, Wang DD, Tinker LF, Gopal S, et al. Metabolic predictors of incident coronary heart disease in women. Circulation. 2018;137:841\u201353.","journal-title":"Circulation."},{"key":"1873_CR17","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1373\/clinchem.2012.199133","volume":"59","author":"MK Townsend","year":"2013","unstructured":"Townsend MK, Clish CB, Kraft P, Wu C, Souza AL, Deik AA, et al. Reproducibility of metabolomic profiles among men and women in 2 large cohort studies. Clin Chem. 2013;59:1657\u201367.","journal-title":"Clin Chem"},{"key":"1873_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1093\/biomet\/93.3.491","volume":"93","author":"Y Benjamini","year":"2006","unstructured":"Benjamini Y, Krieger AM, Yekutieli D. Adaptive linear step-up procedures that control the false discovery rate. Biometrika. 2006;93:491\u2013507.","journal-title":"Biometrika."},{"key":"1873_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v059.i05","volume":"59","author":"D Tingley","year":"2014","unstructured":"Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. \u201cmediation: R package for causal Mediation analysis.\u201d. J Stat Softw. 2014;59:1\u201338.","journal-title":"J Stat Softw"},{"key":"1873_CR20","doi-asserted-by":"publisher","first-page":"e0148361","DOI":"10.1371\/journal.pone.0148361","volume":"11","author":"JE Ho","year":"2016","unstructured":"Ho JE, Larson MG, Ghorbani A, Cheng S, Chen MH, Keyes M, et al. Metabolomic profiles of body mass index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes. PLoS ONE. 2016;11:e0148361.","journal-title":"PLoS ONE"},{"key":"1873_CR21","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR, Muehlbauer MJ, Stevens RD, Lien LF. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311\u201326.","journal-title":"Cell Metab"},{"key":"1873_CR22","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.2337\/dc17-1642","volume":"40","author":"Q Wang","year":"2017","unstructured":"Wang Q, Holmes MV, Davey Smith G, Ala-Korpela M. Genetic support for a causal role of insulin resistance on circulating branched-chain amino acids and inflammation. Diabetes Care. 2017;40:1779\u201386.","journal-title":"Diabetes Care"},{"key":"1873_CR23","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1172\/JCI44442","volume":"121","author":"EP Rhee","year":"2011","unstructured":"Rhee EP, Cheng S, Larson MG, Walford GA, Lewis GD, McCabe E, et al. Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans. J Clin Invest. 2011;121:1402\u201311.","journal-title":"J Clin Invest"},{"key":"1873_CR24","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/ijo.2015.65","volume":"39","author":"H-H Chen","year":"2015","unstructured":"Chen H-H, Tseng YJ, Wang S-Y, Tsai Y-S, Chang C-S, Kuo T-C, et al. The metabolome profiling and pathway analysis in metabolic healthy and abnormal obesity. Int J Obes. 2015;39:1241\u20138.","journal-title":"Int J Obes"},{"key":"1873_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1196\/annals.1320.003","volume":"1033","author":"CJ Rebouche","year":"2004","unstructured":"Rebouche CJ. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism. Ann N. Y Acad Sci. 2004;1033:30\u201341. https:\/\/doi.org\/10.1196\/annals.1320.003","journal-title":"Ann N. Y Acad Sci"},{"key":"1873_CR26","doi-asserted-by":"crossref","unstructured":"Dickerman BA, Ebot EM, Healy BC, Wilson KM, Eliassen AH, Ascherio A, et al. A Metabolomics analysis of adiposity and advanced prostate cancer risk in the health professionals follow-up study. Metabolites. 2020;10:99.","DOI":"10.3390\/metabo10030099"},{"key":"1873_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/db12-0466","volume":"62","author":"MG Schooneman","year":"2013","unstructured":"Schooneman MG, Vaz FM, Houten SM, Soeters MR. Acylcarnitines: reflecting or inflicting insulin resistance? Diabetes. 2013;62:1\u20138.","journal-title":"Diabetes."},{"key":"1873_CR28","doi-asserted-by":"publisher","first-page":"25","DOI":"10.7150\/ijms.13800","volume":"13","author":"K Srikanthan","year":"2016","unstructured":"Srikanthan K, Feyh A, Visweshwar H, Shapiro JI, Sodhi K. Systematic review of metabolic syndrome biomarkers: a panel for early detection, management, and risk stratification in the west virginian population. Int J Med Sci. 2016;13:25\u201338.","journal-title":"Int J Med Sci"},{"key":"1873_CR29","doi-asserted-by":"crossref","unstructured":"Dibaba DT, Braithwaite D, Akinyemiju T. Metabolic syndrome and the risk of breast cancer and subtypes by race, menopause and BMI. Cancers. 2018;10:299.","DOI":"10.3390\/cancers10090299"},{"key":"1873_CR30","doi-asserted-by":"crossref","unstructured":"Zeleznik OA, Balasubramanian R, Ren Y, Tobias DK, Rosner BA, Peng C, et al. Branched chain amino acids and risk of breast cancer. JNCI Cancer Spectr. 2021;5:pkab059.","DOI":"10.1093\/jncics\/pkab059"},{"key":"1873_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-73499-x","volume":"10","author":"DK Tobias","year":"2020","unstructured":"Tobias DK, Hazra A, Lawler PR, Chandler PD, Chasman DI, Buring JE, et al. Circulating branched-chain amino acids and long-term risk of obesity-related cancers in women. Sci Rep. 2020;10:16534.","journal-title":"Sci Rep."},{"key":"1873_CR32","doi-asserted-by":"publisher","first-page":"553332","DOI":"10.3389\/fonc.2020.553332","volume":"10","author":"M Li","year":"2020","unstructured":"Li M, Song L, Yuan J, Zhang D, Zhang C, Liu Y, et al. Association between serum insulin and C-peptide levels and breast cancer: an updated systematic review and meta-analysis. Front Oncol. 2020;10:553332.","journal-title":"Front Oncol"},{"key":"1873_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/ijc.21861","volume":"119","author":"M Verheus","year":"2006","unstructured":"Verheus M, Peeters PHM, Rinaldi S, Dossus L, Biessy C, Olsen A, et al. Serum C-peptide levels and breast cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006;119:659\u201367.","journal-title":"Int J Cancer"},{"key":"1873_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1158\/1055-9965.EPI-06-0693","volume":"16","author":"AH Eliassen","year":"2007","unstructured":"Eliassen AH, Tworoger SS, Mantzoros CS, Pollak MN, Hankinson SE. Circulating insulin and c-peptide levels and risk of breast cancer among predominately premenopausal women. Cancer Epidemiol Biomark Prev. 2007;16:161\u20134.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1873_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1408-4","volume":"17","author":"M His","year":"2019","unstructured":"His M, Viallon V, Dossus L, Gicquiau A, Achaintre D, Scalbert A, et al. Prospective analysis of circulating metabolites and breast cancer in EPIC. BMC Med. 2019;17:178.","journal-title":"BMC Med"},{"key":"1873_CR36","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.freeradbiomed.2010.11.023","volume":"50","author":"SS Davies","year":"2011","unstructured":"Davies SS, Roberts LJ. F2-isoprostanes as an indicator and risk factor for coronary heart disease. Free Radic Biol Med. 2011;50:559\u201366.","journal-title":"Free Radic Biol Med"},{"key":"1873_CR37","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1038\/oby.2011.292","volume":"20","author":"D Il\u2019yasova","year":"2012","unstructured":"Il\u2019yasova D, Wang F, Spasojevic I, Base K, D\u2019Agostino RB, Wagenknecht LE. Urinary F2-isoprostanes, obesity, and weight gain in the IRAS cohort. Obesity. 2012;20:1915\u201321.","journal-title":"Obesity"},{"key":"1873_CR38","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/429149a","volume":"429","author":"S Nemoto","year":"2004","unstructured":"Nemoto S, Finkel T. Ageing and the mystery at Arles. Nature. 2004;429:149\u201352.","journal-title":"Nature."},{"key":"1873_CR39","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1200\/JCO.2008.19.7970","volume":"27","author":"Q Dai","year":"2009","unstructured":"Dai Q, Gao Y-T, Shu X-O, Yang G, Milne G, Cai Q, et al. Oxidative stress, obesity, and breast cancer risk: results from the Shanghai Women\u2019s Health Study. J Clin Oncol. 2009;27:2482\u20138.","journal-title":"J Clin Oncol"},{"key":"1873_CR40","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-015-3391-6","volume":"151","author":"JS Sisti","year":"2015","unstructured":"Sisti JS, Lindstr\u00f6m S, Kraft P, Tamimi RM, Rosner BA, Wu T, et al. Premenopausal plasma carotenoids, fluorescent oxidation products, and subsequent breast cancer risk in the nurses\u2019 health studies. Breast Cancer Res Treat. 2015;151:415\u201325.","journal-title":"Breast Cancer Res Treat"},{"key":"1873_CR41","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/EDE.0000000000000685","volume":"28","author":"HB Nichols","year":"2017","unstructured":"Nichols HB, Anderson C, White AJ, Milne GL, Sandler DP. Oxidative stress and breast cancer risk in premenopausal women. Epidemiology. 2017;28:667\u201374.","journal-title":"Epidemiology."},{"key":"1873_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/978-3-319-42542-9_3","volume":"208","author":"RT Fortner","year":"2016","unstructured":"Fortner RT, Katzke V, K\u00fchn T, Kaaks R. Obesity and breast cancer. Recent Results Cancer Res. 2016;208:43\u201365.","journal-title":"Recent Results Cancer Res"},{"key":"1873_CR43","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0960-0760(03)00360-1","volume":"86","author":"ER Simpson","year":"2003","unstructured":"Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003;86:225\u201330.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1873_CR44","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0960-0760(96)00100-8","volume":"59","author":"C Zhou","year":"1996","unstructured":"Zhou C, Zhou D, Esteban J, Murai J, Siiteri PK, Wilczynski S, et al. Aromatase gene expression and its exon I usage in human breast tumors. Detection of aromatase messenger RNA by reverse transcription-polymerase chain reaction. J Steroid Biochem Mol Biol. 1996;59:163\u201371.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1873_CR45","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/0046-8177(94)90127-9","volume":"25","author":"H Sasano","year":"1994","unstructured":"Sasano H, Nagura H, Harada N, Goukon Y, Kimura M. Immunolocalization of aromatase and other steroidogenic enzymes in human breast disorders. Hum Pathol. 1994;25:530\u20135.","journal-title":"Hum Pathol"},{"key":"1873_CR46","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1210\/jc.2016-3606","volume":"102","author":"KA Brown","year":"2017","unstructured":"Brown KA, Iyengar NM, Zhou XK, Gucalp A, Subbaramaiah K, Wang H, et al. Menopause is a determinant of breast aromatase expression and its associations with BMI, inflammation, and systemic markers. J Clin Endocrinol Metab. 2017;102:1692\u2013701.","journal-title":"J Clin Endocrinol Metab"},{"key":"1873_CR47","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/00001648-200203000-00013","volume":"13","author":"JW Rich-Edwards","year":"2002","unstructured":"Rich-Edwards JW, Spiegelman D, Garland M, Hertzmark E, Hunter DJ, Colditz GA, et al. Physical activity, body mass index, and ovulatory disorder infertility. Epidemiology. 2002;13:184\u201390.","journal-title":"Epidemiology."},{"key":"1873_CR48","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1158\/1055-9965.EPI-06-0671","volume":"15","author":"SS Tworoger","year":"2006","unstructured":"Tworoger SS, Eliassen AH, Missmer SA, Baer H, Rich-Edwards J, Michels KB, et al. Birthweight and body size throughout life in relation to sex hormones and prolactin concentrations in premenopausal women. Cancer Epidemiol Biomark Prev. 2006;15:2494\u2013501.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1873_CR49","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1093\/jnci\/88.11.756","volume":"88","author":"N Potischman","year":"1996","unstructured":"Potischman N, Swanson CA, Siiteri P, Hoover RN. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. J Natl Cancer Inst. 1996;88:756\u20138.","journal-title":"J Natl Cancer Inst"},{"key":"1873_CR50","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1158\/1055-9965.EPI-17-0595","volume":"27","author":"LC Houghton","year":"2018","unstructured":"Houghton LC, Sisti JS, Hankinson SE, Xie J, Xu X, Hoover RN, et al. Estrogen metabolism in premenopausal women is related to early life body fatness. Cancer Epidemiol Biomark Prev. 2018;27:585\u201393.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"1873_CR51","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.numecd.2021.03.025","volume":"31","author":"K Xu","year":"2021","unstructured":"Xu K, Shi L, Zhang B, Mi B, Yang J, Sun X, et al. Distinct metabolite profiles of adiposity indices and their relationships with habitual diet in young adults. Nutr Metab Cardiovasc Dis. 2021;31:2122\u201330.","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01873-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01873-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01873-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T23:06:39Z","timestamp":1663110399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-01873-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,18]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,10,5]]}},"alternative-id":["1873"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-01873-9","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,18]]},"assertion":[{"value":"11 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The return of the self-administered questionnaires and blood samples were considered to imply consent. The study protocol was approved by the institutional review boards of the Brigham and Women\u2019s Hospital and Harvard T.H. Chan School of Public Health, and those of participating registries as required. The study was performed in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}